441 filings
Page 20 of 23
8-K
cjvr7f8 i71a46akp3u9
15 Nov 12
Other Events
12:00am
8-K
qoptwthg71xcecp1va0
6 Nov 12
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
12:00am
8-K
eaw7stwcy3
31 Aug 12
Entry into a Material Definitive Agreement
12:00am
424B5
b7aieslb8sgqgmhu2r0e
31 Aug 12
Prospectus supplement for primary offering
12:00am
8-K
wc26kv sg8e1p6sgcmqb
31 Aug 12
AcelRx Pharmaceuticals Initiates Third Phase 3 Clinical Trial for ARX-01, the Sufentanil
12:00am
EFFECT
zxwrz3
31 Aug 12
Notice of effectiveness
12:00am
8-K
9cone1sepas3 pciv6l
31 Aug 12
Other Events
12:00am
8-K
xz127x2l o5p
13 Aug 12
AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
12:00am
8-K
0cezmg
3 Aug 12
AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral
12:00am
8-K
qbovx0fneon55 40v
27 Jul 12
Submission of Matters to a Vote of Security Holders
12:00am
424B3
dnc r8dk52hdn
3 Jul 12
Prospectus supplement
12:00am
EFFECT
4wgn q8yh8fd2r44jq8
2 Jul 12
Notice of effectiveness
12:00am
S-3
hwqvghacc8 89njwy
21 Jun 12
Shelf registration
12:00am
DEF 14A
i2hq5se3vsqcxuwc8bf
21 Jun 12
Definitive proxy
12:00am
D
m75lh52 77
7 Jun 12
$10M in equity / options / securities to be acquired, sold $10M, 10 investors
12:00am
8-K
uav3qe0unuejc006x
4 Jun 12
AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million
12:00am